Acousia To Refresh Stagnant Hearing Loss Space With New Potassium Channel Approach

The German biotech plans to prevent chemotherapy-induced hearing loss and treat chronic hearing loss by targeting a potassium channel in the ear’s sensory hair cells as it tackles a widespread but side-lined area.  

Emerging Company Profile, Acousia Therapeutics
Hearing Loss Is A Significant Public Health Problem, Affecting Billions • Source: Shutterstock

More from Emerging Company Profiles

More from Start-Ups & SMEs